Juliet Hull

- News
Pandemic poses opportunity to online learning platform OpenLearning
Public
- News
Novatti partners with Ripple for global blockchain payments network
Public
- Market Update
Markets stage a recovery, but is the selling over?
Public
- Opinion
Is ASX: OOO the riskiest or smartest oil investment?
Public

Crowd Media adds voice cloning for immersive celebrity experiences in AI deal
- Review
- January 27, 2021
Research Note - Rise of the Cashless Economy
- Review
- June 3, 2020
Three Tech Stocks Under 10c Positioned to Capitalise on Global Coronavirus Shutdowns
- Review
- March 13, 2020
Novatti launches new payments platform for purpose-issued Visa cards
- Review
- September 29, 2020
Retired NFL players endorse Zilosul, Paradigm’s osteoarthritis drug trials
- Review
- March 24, 2020

Universal Biosensors partners with Peter Mac for handheld cancer diagnosis device
- News
How BCAL Diagnostics is improving minimally invasive methods of early cancer detection
- News
4DMedical’s clinical pilot program to progress following successful first phase
- News
Curing sickness with viruses: How Imugene is using oncolytic viruses to treat cancer
- News
IPO Watch: Lumos to accelerate decentralised healthcare diagnostics with $187m float
- News

- News
Truscreen expands market for real time digital diagnostic testing device
Ahh the pap smear. The daunting, uncomfortable and downright annoying process of having a cervical swab taken to be tested for cancerous or precancerous cells, only to be repeated in 3-5 years time. Despite being an important aspect of women’s health – COVID-19, uncomfortable gyno appointments, and misinformation means that booking in for that test
Read More
Public